BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32900536)

  • 21. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.
    Arya SC; Agarwal N
    Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098
    [No Abstract]   [Full Text] [Related]  

  • 22. Indications for the HPV vaccine in adolescents: a review of the literature.
    Soares GR; Vieira Rda R; Pellizzer EP; Miyahara GI
    J Infect Public Health; 2015; 8(2):105-16. PubMed ID: 25453595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus in head and neck cancer.
    Palma DA; Nichols AC
    CMAJ; 2014 Mar; 186(5):370. PubMed ID: 24295862
    [No Abstract]   [Full Text] [Related]  

  • 24. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
    Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR
    Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV Vaccine Slashes Rates of Oral Infection.
    Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How strong and how wide is the link between HPV and oropharyngeal cancer?
    Franceschi S; Muñoz N; Snijders PJ
    Lancet; 2000 Sep; 356(9233):871-2. PubMed ID: 11036888
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
    BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge and Attitudes of Women towards Human Papilloma Virus and HPV Vaccine in Thulamela Municipality of Vhembe District in Limpopo Province, South Africa.
    Ramathuba DU; Ngambi D
    Afr J Reprod Health; 2018 Sep; 22(3):111-119. PubMed ID: 30381938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA approves quadrivalent HPV vaccine for use in males ages 9-26 years.
    Garg A; Guez G
    Dent Implantol Update; 2011 Mar; 22(3):23-4. PubMed ID: 21425752
    [No Abstract]   [Full Text] [Related]  

  • 32. Who should be vaccinated against HPV?
    Canfell K
    BMJ; 2015 May; 350():h2244. PubMed ID: 25985329
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.
    Ahn J; Peng S; Hung CF; Roden RBS; Best SR
    Laryngoscope; 2018 Jan; 128(1):E16-E20. PubMed ID: 28868617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
    Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus (HPV): making the case for 'Immunisation for All'.
    Prue G; Lawler M; Baker P; Warnakulasuriya S
    Oral Dis; 2017 Sep; 23(6):726-730. PubMed ID: 27492979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Expanded Impact of Human Papillomavirus Vaccine.
    Pahud BA; Ault KA
    Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Literacy Approaches to Improving Communication between Dental Hygienists and Patients for HPV-Related Oral Cancer Prevention.
    Thompson EL; Daley EM; Vamos CA; Horowitz AM; Catalanotto FA; DeBate RD; Merrell LK; Griner SB; Vazquez-Otero C; Kline NS
    J Dent Hyg; 2017 Aug; 91(4):37-45. PubMed ID: 29118082
    [No Abstract]   [Full Text] [Related]  

  • 38. HPV: diagnosis, prevention, and treatment.
    Hathaway JK
    Clin Obstet Gynecol; 2012 Sep; 55(3):671-80. PubMed ID: 22828099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HPV: Carcinogenic implications and preventive measures].
    Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
    Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten Years of Human Papillomavirus Vaccination in the United States.
    Markowitz LE; Gee J; Chesson H; Stokley S
    Acad Pediatr; 2018 Mar; 18(2S):S3-S10. PubMed ID: 29502635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.